Business ❯ Finance ❯ Market Analysis
Analyst Recommendations Price Targets Analyst Reports Morgan Stanley Analyst Predictions Analyst Opinions Analyst Coverage Analyst Upgrades Investment Recommendations Goldman Sachs
Analysts say rising Austedo sales alongside Teva's move into branded drugs could lift the stock if the company sustains execution.